Please Wait

Applying Filters...

FDA approvals drop 8% in 2025, with fewer blockbusters; Brinsupri, Rhapsido make it to first-in-class list

Data Compilation
#PharmaFlow

Pipeline Prospector February 2026 highlights: Gilead buys Arcellx for US$ 7.8 bn; FDA okays Vanda’s psychotic pill

Stock Recap
#PipelineProspector

NAFTIFINE HCL

ACCESS ALL DATA, CHEMISTRY

ACTIVE PHARMA INGREDIENTS

18 API Suppliers, 8 USDMF, 2 EU WC, 2 KDMF, 3 NDC API, 11 Listed Suppliers, $ API Reference Price

DEVELOPMENTS

11 Drugs in Development

11 Drugs in Development

INTERMEDIATES

3 Intermediate Suppliers

3 Intermediate Suppliers

FINISHED DOSAGE FORMULATIONS

22 FDF Dossiers, 10 FDA Orange Book, 10 Europe, 2 Listed Dossiers

DRUG PRODUCT COMPOSITIONS

GEL;TOPICAL - 1%, CREAM;TOPICAL - 1% **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, CREAM;TOPICAL - 2%, GEL;TOPICAL - 2%

RELATED EXCIPIENT COMPANIES

6 Nanjing Well Pharmaceutical, 3 Kirsch Pharma, 4 Actylis, 8 BASF, 1 Corel Pharma Chem, 1 Esteem Industries, 2 Finar, 5 Gangwal Chemicals, 3 Gloria Interchem, 2 Lubrizol Life Science Health, 1 Microlex e.U, 1 Nanjing Bold Chemical, 10 Seppic, 1 Valens Pharmachem

EXCIPIENTS BY APPLICATIONS

22 Solubilizers, 20 Topical, 13 Parenteral, 11 Emulsifying Agents, 10 Surfactant & Foaming Agents, 9 Thickeners and Stabilizers, 4 Film Formers & Plasticizers, 2 Direct Compression, 2 Rheology Modifiers, 1 Controlled & Modified Release, 1 Granulation, 1 Lubricants & Glidants, 1 Co-Processed Excipients, 1 API Stability Enhancers

DIGITAL CONTENT

3 News #PharmaBuzz

3 News #PharmaBuzz

GLOBAL SALES INFORMATION

4 US Medicaid Prescriptions, 7 Regulatory FDF Prices

MARKET PLACE

16 APIs

16 APIs

PATENTS & EXCLUSIVITIES

6 US Patents

6 US Patents

REF. STANDARDS & IMPURITIES

3 USP, 1 Others

$ Xls

Filters

CREAM;TOPICAL - 1% **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

CREAM;TOPICAL - 2%

GEL;TOPICAL - 2%

GEL;TOPICAL - 1%

X

Contact us
to update this info

Privacy policy
Terms and conditions
Disclaimers
Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.

NAFTIFINE HCL

NAFTIFINE HCL

ACCESS ALL DATA

CHEMISTRY

Discover Molecule Insights

ACTIVE PHARMA INGREDIENTS

18 API Suppliers

8 USDMF

2 EU WC

2 KDMF

3 NDC API

11 Listed Suppliers

$ API Reference Price

DEVELOPMENTS

11 Drugs in Development

INTERMEDIATES

3 Intermediate Suppliers

FINISHED DOSAGE FORMULATIONS

22 FDF Dossiers

10 FDA Orange Book

10 Europe

2 Listed Dossiers

DRUG PRODUCT COMPOSITIONS

GEL;TOPICAL - 1%

CREAM;TOPICAL - 1% **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

CREAM;TOPICAL - 2%

GEL;TOPICAL - 2%

RELATED EXCIPIENT COMPANIES

6 Nanjing Well Pharmaceutical

3 Kirsch Pharma

4 Actylis

8 BASF

1 Corel Pharma Chem

1 Esteem Industries

2 Finar

5 Gangwal Chemicals

3 Gloria Interchem

2 Lubrizol Life Science Health

1 Microlex e.U

1 Nanjing Bold Chemical

10 Seppic

1 Valens Pharmachem

EXCIPIENTS BY APPLICATIONS

22 Solubilizers

20 Topical

13 Parenteral

11 Emulsifying Agents

10 Surfactant & Foaming Agents

9 Thickeners and Stabilizers

4 Film Formers & Plasticizers

2 Direct Compression

2 Rheology Modifiers

1 Controlled & Modified Release

1 Granulation

1 Lubricants & Glidants

1 Co-Processed Excipients

1 API Stability Enhancers

DIGITAL CONTENT

3 News #PharmaBuzz

GLOBAL SALES INFORMATION

4 US Medicaid Prescriptions

7 Regulatory FDF Prices

MARKET PLACE

16 APIs

PATENTS & EXCLUSIVITIES

6 US Patents

REF. STANDARDS & IMPURITIES

3 USP

1 Others

Filters

CREAM;TOPICAL - 1% Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons